Accumulating evidence revealed that the inactivation of Akt and the activation of Foxo1 via inhibiting insulin receptor substrate 1 (IRS1) and insulin receptor substrate 2 (IRS2) might act as the underlying mechanism of metabolic syndromes (Guo, 2014). The gene discussed is IRS2; the disease is metabolic syndrome.